Biotin: All what you need to know about it

Biotin is a carboxylase enzyme that supports the various metabolic reactions involved in the branching of amino acids, such as the synthesis of the amino acid phenylalanine.

The aim of the study was to determine whether biotin was present in the blood of women complaining of hair loss. However, there was no evidence of it, and there was no evidence of its presence in blood samples of patients complaining of hair loss, such as men.

Botins were also found in the blood samples of women who complained of hair loss, but only in a small proportion of women.

No cases of messenger in the blood samples of women with hair loss were reported after receiving high doses of the vitamin, but there was evidence of an association between high levels of vitamin B12 and the presence of messenger. There is also a correlation between the number of reported cases and a higher incidence of skin cancer if the high-dose vitamin was administered or if it was taken in combination with other anti-inflammatory drugs.

There is no evidence that the drug interferes with biotin metabolism or biotin uptake; instead, the associated symptoms such as hair loss and skin cancer must be treated.

If a biotin deficiency is suspected, the serum biotin values must be determined and the deficiency remedied. At the same time, the cause of the problem, such as a deficiency of the liver, kidney or other organs, must be systematically addressed and treated if necessary. The cause should not be sought or treated unless a cause is addressed, unless it is the result of a serious illness or illness.

There are several ways in which hereditary disorders of biotinidase deficiency lead to a secondary biotin deficiency. In addition, antispasmodic drugs used in patients with epilepsy increase the risk of biodegradation (see drug interactions for more information on Biotsins and Anticons vulsants).

This could be because antispasmodic treatment increases biotin catabolism, which leads to a reduced absorption of biotins in the intestine (see Figure 1 above). Furthermore, intestinal absorption is reduced because the absence of biotinidase prevents the release of biotsins from dietary proteins. The ability to bind our own biotsin to carboxylases and histones is also impaired, which increases the risk of biodegradation and subsequent loss of biotin-specific proteins (e.g. bifidobotanins).

Foods in nutrient-rich forms contain other naturally occurring substances that can have beneficial effects on health, such as vitamins, minerals, amino acids and other nutrients.

For more information on building a healthy diet, see the Dietary Guidelines for Americans and the American Academy of Nutrition and Dietetics (AAP).

Biotin is a water-soluble vitamin commonly classified as a B complex vitamin and widely used in food. Good food sources are fruits, vegetables, nuts, seeds, legumes, fish, eggs, dairy products and nuts. The food demand for biotin has increased in recent years due to the use of anticonvulsants, which can disrupt the absorption of B-complex vitamins by the body's immune system and probably also increase the degradation of biotins into inactive metabolites.

Since its first discovery in 1927, 40 years of additional research have been required to establish biotin as vitamin 1.0. The Institute of Medicine noted that reports of adverse events were absent when the Dietary Reference Intake (DRI) for biotins was introduced in 1998.

Biotin concentrations in the blood have been reduced, but this effect has not been shown in humans. Some were said to show an increase due to reduced carboxylase activity (which is considered a marker of biotin status), but these effects have not been demonstrated in humans. A 2009 study in the Journal of the American Medical Association (JAMA) found that biotin-dependent carboxylase activity decreased in rats. These included a reduction in blood levels and an increased bioton catabolism, as well as a reduction in blood sugar and blood sugar levels.

Biotin affects classical signaling pathways at the posttranscriptional level, such as the transcription pathway, and also in the metabolic pathways of the liver.

Signs of overt biotin deficiency have been observed in people who consume large amounts of raw protein. Clinical findings for open biotin deficiencies include hair loss, impaired immune function and anemia. A significant decrease in the bioavailability of biotins [1] is caused by the presence of a protein that binds to biotin-1 but not to the protein biotin-2. In addition, a rareBiotin transporter defect has been identified in humans [3, 4, 5, 6, 7].

Cited Sources

https://lpi.oregonstate.edu/book/export/html/47 
https://ods.od.nih.gov/factsheets/Biotin-HealthProfessional/ 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648722/ 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989391/